Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - INTEREST INCOME & EXPENSE
Interest Income & Expense ENTA - Enanta Pharmaceuticals, Inc.
10.9 M
LAST VALUE
163.72%
2 YEAR CAGR
4.40%
5 YEAR CAGR
89.83%
10 YEAR CAGR